Literature DB >> 20204321

High normal fasting glucose level in obese youth: a marker for insulin resistance and beta cell dysregulation.

G O'Malley1, N Santoro, V Northrup, E D'Adamo, M Shaw, S Eldrich, S Caprio.   

Abstract

AIMS/HYPOTHESIS: A high but normal fasting plasma glucose level in adults is a risk factor for future development of type 2 diabetes mellitus and cardiovascular disease. We investigated whether normal fasting plasma glucose levels (<5.60 mmol/l) are associated with decreases in insulin sensitivity and beta cell function, as well as an adverse cardiovascular profile in obese youth.
METHODS: We performed a cross-sectional analysis in a multiethnic sample of 1,020 obese youth (614 girls and 406 boys; mean age 12.9 years [CI 95% 12.7-13.1], BMI z score 2.34 [CI 95% 2.31-2.38]) with normal fasting plasma glucose. All participants had a standard OGTT, with calculation of indices of insulin sensitivity and beta cell function. For the analysis, prepubertal and pubertal participants were stratified into quartiles of normal fasting plasma glucose.
RESULTS: We observed a significant increase in fasting insulin and AUC 2 h glucose across quartiles. Pronounced changes were observed in insulin sensitivity and secretion, particularly in the pubertal group. Moreover, the odds of presenting with impaired glucose tolerance increased by 4.5% with each 0.06 mmol/l increase in fasting plasma glucose. No significant differences in cardiovascular indices were seen across quartiles. CONCLUSIONS/
INTERPRETATION: These data suggest that in obese youth, independent of age, BMI z score, sex, family history and ethnicity, insulin sensitivity and secretion decline when moving from low to high normal fasting plasma glucose. The simple measure of fasting plasma glucose could assist clinicians in identifying children for targeted diabetes screening and subsequent lifestyle management.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20204321     DOI: 10.1007/s00125-010-1693-0

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  33 in total

1.  Normal fasting plasma glucose and risk of type 2 diabetes diagnosis.

Authors:  Gregory A Nichols; Teresa A Hillier; Jonathan B Brown
Journal:  Am J Med       Date:  2008-06       Impact factor: 4.965

2.  The association between metabolic control and prevalent macrovascular disease in Type 2 diabetes: the VA Cooperative Study in diabetes.

Authors:  M Sue Kirkman; Madeline McCarren; Jayendra Shah; William Duckworth; Carlos Abraira
Journal:  J Diabetes Complications       Date:  2006 Mar-Apr       Impact factor: 2.852

3.  Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp.

Authors:  M Matsuda; R A DeFronzo
Journal:  Diabetes Care       Date:  1999-09       Impact factor: 19.112

4.  Glucoregulatory physiology in subjects with low-normal, high-normal, or impaired fasting glucose.

Authors:  Samuel Dagogo-Jack; Hasan Askari; Gunjan Tykodi
Journal:  J Clin Endocrinol Metab       Date:  2009-03-10       Impact factor: 5.958

5.  Intensive diabetes therapy and carotid intima-media thickness in type 1 diabetes mellitus.

Authors:  David M Nathan; John Lachin; Patricia Cleary; Trevor Orchard; David J Brillon; Jye-Yu Backlund; Daniel H O'Leary; Saul Genuth
Journal:  N Engl J Med       Date:  2003-06-05       Impact factor: 91.245

6.  Incidence of diabetes in youth in the United States.

Authors:  Dana Dabelea; Ronny A Bell; Ralph B D'Agostino; Giuseppina Imperatore; Judith M Johansen; Barbara Linder; Lenna L Liu; Beth Loots; Santica Marcovina; Elizabeth J Mayer-Davis; David J Pettitt; Beth Waitzfelder
Journal:  JAMA       Date:  2007-06-27       Impact factor: 56.272

Review 7.  Obesity in children and young people: a crisis in public health.

Authors:  T Lobstein; L Baur; R Uauy
Journal:  Obes Rev       Date:  2004-05       Impact factor: 9.213

Review 8.  The pathophysiology of cardiovascular disease in diabetes mellitus and the future of therapy.

Authors:  Joseph Emmanuel Thomas; JoAnne Micale Foody
Journal:  J Cardiometab Syndr       Date:  2007

9.  Primary defects in beta-cell function further exacerbated by worsening of insulin resistance mark the development of impaired glucose tolerance in obese adolescents.

Authors:  Anna M G Cali; Chiara Dalla Man; Claudio Cobelli; James Dziura; Aisha Seyal; Melissa Shaw; Karin Allen; Shu Chen; Sonia Caprio
Journal:  Diabetes Care       Date:  2008-12-23       Impact factor: 19.112

10.  Oral disposition index predicts the development of future diabetes above and beyond fasting and 2-h glucose levels.

Authors:  Kristina M Utzschneider; Ronald L Prigeon; Mirjam V Faulenbach; Jenny Tong; Darcy B Carr; Edward J Boyko; Donna L Leonetti; Marguerite J McNeely; Wilfred Y Fujimoto; Steven E Kahn
Journal:  Diabetes Care       Date:  2008-10-28       Impact factor: 19.112

View more
  25 in total

1.  Children with metabolically healthy obesity have a worse metabolic profile compared to normal-weight peers: a cross-sectional study.

Authors:  Anastasios Serbis; Vasilieios Giapros; Stavroula A Paschou; Ekaterini Siomou
Journal:  Endocrine       Date:  2021-05-22       Impact factor: 3.633

2.  Oxidized Derivatives of Linoleic Acid in Pediatric Metabolic Syndrome: Is Their Pathogenic Role Modulated by the Genetic Background and the Gut Microbiota?

Authors:  Domenico Tricò; Anna Di Sessa; Sonia Caprio; Naga Chalasani; Wanqing Liu; Tiebing Liang; Joerg Graf; Raimund I Herzog; Casey D Johnson; Giuseppina Rosaria Umano; Ariel E Feldstein; Nicola Santoro
Journal:  Antioxid Redox Signal       Date:  2017-04-07       Impact factor: 8.401

3.  Elevated α-Hydroxybutyrate and Branched-Chain Amino Acid Levels Predict Deterioration of Glycemic Control in Adolescents.

Authors:  Domenico Tricò; Hetty Prinsen; Cosimo Giannini; Robin de Graaf; Christoph Juchem; Fangyong Li; Sonia Caprio; Nicola Santoro; Raimund I Herzog
Journal:  J Clin Endocrinol Metab       Date:  2017-07-01       Impact factor: 5.958

4.  Evidence Brief--Trends and projections of obesity among Canadians.

Authors:  C Bancej; B Jayabalasingham; R W Wall; D P Rao; M T Do; M de Groh; G C Jayaraman
Journal:  Health Promot Chronic Dis Prev Can       Date:  2015-09       Impact factor: 3.240

5.  Triglycerides/glucose index is a useful surrogate marker of insulin resistance among adolescents.

Authors:  B Kang; Y Yang; E Y Lee; H K Yang; H-S Kim; S-Y Lim; J-H Lee; S-S Lee; B-K Suh; K-H Yoon
Journal:  Int J Obes (Lond)       Date:  2017-01-20       Impact factor: 5.095

6.  Continuous glucose monitoring and its relationship to hemoglobin A1c and oral glucose tolerance testing in obese and prediabetic youth.

Authors:  Christine L Chan; Laura Pyle; Lindsey Newnes; Kristen J Nadeau; Philip S Zeitler; Megan M Kelsey
Journal:  J Clin Endocrinol Metab       Date:  2014-12-22       Impact factor: 5.958

7.  Association between different growth curve definitions of overweight and obesity and cardiometabolic risk in children.

Authors:  Lisa Kakinami; Mélanie Henderson; Edgard E Delvin; Emile Levy; Jennifer O'Loughlin; Marie Lambert; Gilles Paradis
Journal:  CMAJ       Date:  2012-04-30       Impact factor: 8.262

8.  High-Normal Adolescent Fasting Plasma Glucose Is Associated With Poorer Midlife Brain Health: Bogalusa Heart Study.

Authors:  Owen Carmichael; Patrick Stuchlik; Sreekrishna Pillai; Geert-Jan Biessels; Ram Dhullipudi; Anna Madden-Rusnak; Shane Martin; Daniel S Hsia; Vivian Fonseca; Lydia Bazzano
Journal:  J Clin Endocrinol Metab       Date:  2019-10-01       Impact factor: 5.958

9.  The rs626283 Variant in the MBOAT7 Gene is Associated with Insulin Resistance and Fatty Liver in Caucasian Obese Youth.

Authors:  Giuseppina R Umano; Sonia Caprio; Anna Di Sessa; Naga Chalasani; Daniel J Dykas; Bridget Pierpont; Allen E Bale; Nicola Santoro
Journal:  Am J Gastroenterol       Date:  2018-02-27       Impact factor: 10.864

10.  Effect of dietary patterns differing in carbohydrate and fat content on blood lipid and glucose profiles based on weight-loss success of breast-cancer survivors.

Authors:  Henry J Thompson; Scot M Sedlacek; Devchand Paul; Pamela Wolfe; John N McGinley; Mary C Playdon; Elizabeth A Daeninck; Sara N Bartels; Mark R Wisthoff
Journal:  Breast Cancer Res       Date:  2012-01-06       Impact factor: 6.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.